Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
ERAS · against 230 other Healthcare companies of similar size
Ranked #213 of 231 · scores higher than 7% of peers
Bars: peers in each 10-point band of the profitability score16 peers with a profitability score of 10–19, including ERAS · Click a bar to see the companies
Mainly because of its return on assets and return on invested capital, which are weaker than most Healthcare peers.
| Metric | ERAS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 223 reported | -74.9% | 8.2% | 5% | 33% | |
| Operating marginHigher is better · 210 reported | Not reported | 10.4% | — | — | 33% |
| Return on assetsHigher is better · 221 reported | -66.0% | 2.7% | 3% | 33% | |
| Return on equityHigher is better · 216 reported | -78.2% | 7.4% | 9% | Context only | |
| Gross marginHigher is better · 239 reported | 0.0% | 49.5% | 3% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 321.5B INR (≈$3.9B) | 100 | 70 | |
| 3 | 51.3B ZAR (≈$2.8B) | 99 | 73 | |
| 3 | 3.8B USD | 99 | 71 | |
| 3 | 2.7B USD | 99 | 84 | |
| 210 | 3.7B USD | 13 | 31 | |
| 210 | 5.7B USD | 13 | 30 | |
| 210 | 3.9B USD | 13 | 52 | |
| 213 | 3.4B USD | 12 | 35 | |
| 213 | 5.1B USD | 12 | 35 | |
| 215 | 3.9B USD | 10 | 47 | |
| 215 | 6.2B USD | 10 | 44 | |
| 215 | 8.8B USD | 10 | 31 | |
| 215 | 3.0B USD | 10 | 11 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score